The pleomorphic phenotype of neurosarcoidosis
- PMID: 39702809
- DOI: 10.1007/s10072-024-07914-w
The pleomorphic phenotype of neurosarcoidosis
Conflict of interest statement
Declarations. Ethics approval: This project was approved by the Fleni ethics committee. All included patients provided their consent for the dissemination of their cases and supplementary studies for academic and scientific purposes. Competing interests: The authors have nothing to disclose related to this article.
References
-
- Valeyre D, Bernaudin JF (2014) Clinical presentation of sarcoidosis and diagnostic work-up. Semin Respir Crit Care Med 35(3):336–351. https://doi.org/10.1055/s-0034-1381229 - DOI - PubMed
-
- Arkema EV, Cozier YC (2018) Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis 9(11):227–240. https://doi.org/10.1177/204062231879019 - DOI - PubMed - PMC
-
- Baughman RP, Field S, Costabel U (2016) Sarcoidosis in America. analysis based on health care use. Ann Am Thorac Soc 13(8):1244–1252. https://doi.org/10.1513/AnnalsATS.201511-760OC - DOI - PubMed
-
- Voortman M, Drent M, Baughman RP (2019) Management of neurosarcoidosis: a clinical challenge. Curr Opin Neurol 32(3):475–483. https://doi.org/10.1097/WCO.0000000000000684 - DOI - PubMed - PMC
-
- Nozaki K, Judson MA, Neurosarcoidosis (2012) Clinical manifestations, diagnosis and treatment. Presse Med 41(6 Pt 2). https://doi.org/10.1016/j.lpm.2011.12.017 . e331-48
Publication types
LinkOut - more resources
Full Text Sources